Discover Great Companies Discover Great Clients
Companies Salaries Jobs
Jobs |
Jobs Companies Salary Majors

About the Company

江苏迈威康新药研发有限公司是迈威(上海)生物科技股份有限公司旗下子公司, 2019年根据业务需要由江苏泰康生物医药有限公司的研发部分立而成,有工艺开发、质量研究、ADC药物开发、注册及研发合规、研发支持五个部门。迈威康能够完成工艺转化与放大、支持产品商业化上市的开发全流程工作,目前在研药物品种集中在单克隆抗体和抗体偶联药物(ADC)领域,预期2021年将有1个ADC品种进入临床阶段。

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

honors, qualifications & industry associations

Tags are labelled based on keyword text matching analysis and may be related to the company. For reference only.

Related Industry Tags

Tags are auto-annotated by keyword text matching and may be correlated. For reference only.

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 5,000万(元)
Legal Representative: 刘大涛
Date Established:
Credit Code: 91321291MA1X633RXD
Registered Address: 泰州市药城大道一号QB3一期3006室.

People who follow this company also follow

Competitors (Similar Companies)

医药流通 医药商业 医疗器械 产品分销
“开拓创新,造福病患”
生物科技/生物工程 医药 生物医药 生物科技
“一家致力于中成药、化学药及生物制品的研发、生产、销售及售后服务的医药集团”
“药物研发领域创新型化学产品和服务供应商”
制药/药业 医药 生物医药 原料药
医药 生物医药 生物科技 抗肿瘤药
光电子器件 光电子 耦合器 隔离器
制药/药业 制药 原料药 兽药
生物科技/生物工程 生物科技 氨基酸 葡萄糖
化工/化学 新材料 纳米材料 溶剂
制药/药业 药物研发 制药 药材种植
制药/药业 医药 制药
生物科技 制药 医学研究 CRO
“新药的发现与应用”

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates

养生保健
客服
由百度提供